Biomarkers for predicting response are highly needed, but no biomarkers are widely used till now.<h4>Patients and methods</h4>From February 2018 to April 2019, pan-cancer patients treated with PD-1 or PD-L1 inhibitor as a single agent in our center were included. This evidence concerns the gene CD274 and cancer.